Methods for treating cancers with antibody drug conjugates (ADC) that bind to 191p4d12 proteins

KE8310BUndetermined Publication Date: 2026-07-20AGENSYS INC +1
0 Cites 0 Cited by

Patent Information

Application Number
KE2023014745
Authority / Receiving Office
KE · KE
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-09-16
Publication Date
2026-07-20
Estimated Expiration
2041-09-16
Patent Text Reader

Abstract

Provided herein are methods for the treatment of cancers with antibody drug conjugates (ADC) that bind to 191P4D12 proteins.
Need to check novelty before this filing date? Find Prior Art